Pilot-scale production and characterization of paramyosin, a vaccine candidate for schistosomiasis japonica

Infection and Immunity

Volumn 76, Issue 7, 2008, Pages 3164-3169

  Jiz, Mario ^a,b   Wu, Hai Wei ^a,c,e   Meng, Rui ^c   Pond Tor, Sunthorn ^a   Reynolds, Mindy ^b   Friedman, Jennifer F ^a   Olveda, Remigio ^d   Acosta, Luz ^d   Kurtis, Jonathan D ^a  

^a RHODE ISLAND HOSPITAL   (United States)

^b BROWN UNIVERSITY   (United States)

^c NANJING MEDICAL UNIVERSITY   (China)

^d RESEARCH INSTITUTE FOR TROPICAL MEDICINE   (Philippines)

^e Center for International Health Research   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; HYDROXYAPATITE; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; PARAMYOSIN; HELMINTH ANTIBODY; RECOMBINANT PROTEIN; TROPOMYOSIN; VACCINE;

ANION EXCHANGE; ANTIGENICITY; ARTICLE; CELL INCLUSION; CONTROLLED STUDY; DRUG ISOLATION; DRUG PROTEIN BINDING; DRUG PURIFICATION; ESCHERICHIA COLI; GEL PERMEATION CHROMATOGRAPHY; IMMUNE RESPONSE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHISTOSOMA JAPONICUM; SCHISTOSOMIASIS; ANIMAL; BIOTECHNOLOGY; GENETICS; HUMAN; IMMUNOLOGY; INSTITUTE FOR CANCER RESEARCH MOUSE; ISOLATION AND PURIFICATION; METABOLISM; METHODOLOGY; PARASITOLOGY; PILOT STUDY;

ANIMALS; ANTIBODIES, HELMINTH; BIOTECHNOLOGY; ESCHERICHIA COLI; HUMANS; INCLUSION BODIES; MICE; MICE, INBRED ICR; PILOT PROJECTS; RECOMBINANT PROTEINS; SCHISTOSOMA JAPONICUM; SCHISTOSOMIASIS JAPONICA; TROPOMYOSIN; VACCINES;

EID: 46449116800     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.00409-08     Document Type: Article

References (28)

1. Bergquist, N. R., L. R. Leonardo, and G. F. Mitchell. 2005. Vaccine-linked chemotherapy: can schistosomiasis control benefit from an integrated approach? Trends Parasitol. 21:112-117.
2. Bergquist, R., M. Al-Sherbiny, R. Barakat, and R. Olds. 2002. Blueprint for schistosomiasis vaccine development. Acta Trop. 82:183-192.
3. Chan, M. S., M. E. Woolhouse, and D. A. Bundy. 1997. Human schistosomiasis: potential long-term consequences of vaccination programmes. Vaccine 15:1545-1550.
4. Correa-Oliveira, R., E. J. Pearce, G. C. Oliveira, D. B. Golgher, N. Katz, L. G. Bahia, O. S. Carvalho, G. Gazzinelli, and A. Sher. 1989. The human immune response to defined immunogens of Schistosoma mansoni: elevated antibody levels to paramyosin in stool-negative individuals from two endemic areas in Brazil. Trans. R. Soc. Trop. Med. Hyg. 83:798-804.
5. Deng, J., D. Gold, P. T. LoVerde, and Z. Fishelson. 2003. Inhibition of the complement membrane attack complex by Schistosoma mansoni paramyosin. Infect. Immun. 71:6402-6410.
6. Engels, D., L. Chitsulo, A. Montresor, and L. Savioli. 2002. The global epidemiological situation of schistosomiasis and new approaches to control and research. Acta Trop. 82:139-146.
7. FDA. 1991. List of orphan products designations and approvals. http://www.fda.gov/ohrms/dockets/dailys/00/mar00/030100/lst0094.pdf.
8. Gobert, G. N., and D. P. McManus. 2005. Update on paramyosin in parasitic worms. Parasitol. Int. 54:101-107.
9. Gobert, G. N., D. J. Stenzel, M. K. Jones, D. E. Allen, and D. P. McManus. 1997. Schistosoma japonicum: immunolocalization of paramyosin during development. Parasitology 114:45-52.
10. Kagawa, H., K. Gengyo, A. D. McLachlan, S. Brenner, and J. Karn. 1989. Paramyosin gene (unc-15) of Caenorhabditis elegans. Molecular cloning, nucleotide sequence and models for thick filament structure. J. Mol. Biol. 207:311-333.
11. King, C. H., K. Dickman, and D. J. Tisch. 2005. Reassessment of the cost of chronic helmintic infection: a meta-analysis of disability-related outcomes in endemic schistosomiasis. Lancet 365:1561-1569.
12. Kojima, S., M. Niimura, and T. Kanazawa. 1987. Production and properties of a mouse monoclonal IgE antibody to Schistosoma japonicum. I. Immunol. 139:2044-2049.
13. Laclette, J. P., C. B. Shoemaker, D. Richter, L. Arcos, N. Pante, C. Cohen, D. Bing, and A. Nicholson-Weller. 1992. Paramyosin inhibits complement C1. J. Immunol. 148:124-128.
14. Lanar, D. E., E. J. Pearce, S. L. James, and A. Sher. 1986. Identification of paramyosin as schistosome antigen recognized by intradermally vaccinated mice. Science 234:593-596.
15. Leenstra, T., L. P. Acosta, H. W. Wu, G. C. Langdon, J. S. Solomon, D. L. Manalo, L. Su, M. Jiz, B. Jarilla, A. O. Pablo, S. T. McGarvey, R. M. Olveda, J. F. Friedman, and J. D. Kurtis. 2006. T-helper-2 cytokine responses to Sj97 predict resistance to reinfection with Schistosoma japonicum. Infect. Immun. 74:370-381.
16. Lewis, F. 1998. Schistosomiasis, p. 19.1.5-19.1.6. In J. E. Coligan et al. (ed.), Current protocols in immunology. John Wiley & Sons, Inc., New York, NY.
17. Loukas, A., M. K. Jones, L. T. King, P. J. Brindley, and D. P. McManus. 2001. Receptor for Fc on the surfaces of schistosomes. Infect. Immun. 69:3646-3651.
18. Maizels, R. M., and M. Yazdanbakhsh. 2003. Immune regulation by helminth parasites: cellular and molecular mechanisms. Nat. Rev. Immunol. 3:733-744.
19. McManus, D. P., J. Y. Wong, J. Zhou, C. Cai, Q. Zeng, D. Smyth, Y. Li, B. H. Kalinna, M. J. Duke, and X. Yi. 2001. Recombinant paramyosin (rec-Sj-97) tested for immunogenicity and vaccine efficacy against Schistosoma japonicum in mice and water buffaloes. Vaccine 20:870-578.
20. Ramirez, B. L., J. D. Kurtis, P. M. Wiest, P. Arias, F. Aligui, L. Acosta, P. Peters, and G. R. Olds. 1996. Paramyosin: a candidate vaccine antigen against Schistosoma japonicum. Parasite Immunol. 18:49-52.
21. Rohl, C. A., and R. L. Baldwin. 1997. Comparison of NH exchange and circular dichroism as techniques for measuring the parameters of the helix-coil transition in peptides. Biochemistry 36:8435-8442.
22. Rusconi, F., E. Valton, R. Nguyen, and E. Dufourc. 2001. Quantification of sodium dodecyl sulfate in microliter-volume biochemical samples by visible light spectroscopy. Anal. Biochem. 295:31-37.
23. Solomon, J. S., C. P. Nixon, S. T. McGarvey, L. P. Acosta, D. Manalo, and J. D. Kurtis. 2004. Expression, purification, and human antibody response to a 67 kDa vaccine candidate for schistosomiasis japonica. Protein Expr. Purif. 36:226-231.
24. Webster, M., P. G. Fallon, A. J. Fulford, A. E. Butterworth, J. H. Ouma, G. Kimani, and D. W. Dunne. 1997. Effect of praziquantel and oxamniquine treatment on human isotype responses to Schistosoma mansoni: elevated IgE to adult worm. Parasite Immunol. 19:333-335.
25. Williams, G. M., A. C. Sleigh, Y. Li, Z. Feng, G. M. Davis, H. Chen, A. G. Ross, R. Bergquist, and D. P. McManus. 2002. Mathematical modelling of schistosomiasis japonica: comparison of control strategies in the People's Republic of China. Acta Trop. 82:253-262.
26. Woods, E. F. 1969. Subunit structure of oyster paramyosin. Biochem. I. 113:39-47.
27. Zhang, D. M., W. Q. Pan, L. Qian, M. Duke, L. H. Shen, and D. P. McManus. 2006. Investigation of recombinant Schistosoma japonicum paramyosin fragments for immunogenicity and vaccine efficacy in mice. Parasite Immunol. 28:77-84.
28. Zhou, N. E., C. M. Kay, and R. S. Hodges. 1992. Synthetic model proteins. Positional effects of interchain hydrophobic interactions on stability of two-stranded alpha-helical coiled-coils. J. Biol. Chem. 267:2664- 2670.